Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Transcranial Direct Current Stimulation Potentiation of Fear Extinction in OCD

NCT: NCT05521074 · COMPLETED

NCT IDNCT05521074
StatusCOMPLETED
Start Date2022-09-15
Completion2025-07-31
SponsorMassachusetts General Hospital (OTHER)
First posted
Last updated

Brief Summary

The investigators want to learn more about how human beings learn not to fear and the impact of changing the fear network in the brain using transcranial Direct Current Stimulation (tDCS) in individuals with obsessive compulsive disorder (OCD). The investigators hope this study will help us understand how future treatments can help patients with OCD better control unwanted fear.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑